AsortinoBeta
Charles River Laboratories International, Inc. logo

CRLCharles River Laboratories International, Inc.

NYSEStockHealthcareDiagnostics & Research🇺🇸 United StatesISIN US1598641074criver.com
$288.501.65%
NYSE · at close Sep 4, 2026
Tokenized by
Dinari Inc. logoReality logo
2 issuersOn
Arbitrum One logoBase logoAvalanche C-Chain logoEthereum logo
6 chains

Chart data are delayed by 15 minutes.

1D1.65%
1M+23.23%
3M+55.28%
1Y+77.75%
3Y+37.63%
5Y35.82%

Main metrics

$13.9B
$9.44<0.01% of mkt cap
681.33
-$4.82
928.5K
1.41
$144.2652-week range$303.31

About CRL

Charles River Laboratories International, Inc. is a global drug development services company that supports pharmaceutical, biotechnology, and medical device organizations across the research and preclinical stages. Charles River Laboratories provides research models, discovery services, non-clinical safety assessment, and manufacturing-related testing solutions that help clients evaluate new therapies and products before clinical use. Its business spans three main segments: Research Models and Services, Discovery and Safety Assessment, and Manufacturing Solutions. The company also offers specialized support for biologics, microbial testing, endotoxin testing, and cell-based research, serving customers in life sciences, academia, and government research. Headquartered in Wilmington, Massachusetts, Charles River Laboratories plays a key role in the outsourced research and development ecosystem by supplying the tools, services, and scientific expertise used to advance drug discovery and product safety worldwide.

Similar products

Agilent Technologies Inc. logo
ANYSE
$150.86+0.59%
Agilent Technologies Inc.
Backed Finance logoReality logoDinari Inc. logo
3 issuers · 13 chains
Quest Diagnostics Incorporated logo
DGXNYSE
$237.140.94%
Quest Diagnostics Incorporated
Backed Finance logoReality logoDinari Inc. logo
3 issuers · 14 chains
Danaher Corp. logo
DHRNYSE
$207.661.60%
Danaher Corp.
Backed Finance logoReality logoDinari Inc. logo
3 issuers · 15 chains
Guardant Health Inc. logo
GHNASDAQ
$161.41+0.23%
Guardant Health Inc.
Reality logo
1 issuer · 2 chains